GTC
ROIV icon

Ghost Tree Capital’s Roivant Sciences ROIV Stock Holding History

Ghost Tree Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$9.23M Sell
800,000
-200,000
-20% -$2.28M 2.79% 10
2024
Q2 		$10.6M Sell
1,000,000
-300,000
-23% -$3.29M 3.31% 10
2024
Q1 		$13.7M Buy
1,300,000
+700,000
+117% +$7.55M 3.79% 6
2023
Q4 		$6.74M Buy
600,000
+536,000
+838% +$5.22M 2.2% 9
2023
Q3 		$748K Hold
64,000
– – 0.25% 61
2023
Q2 		$645K Buy
+64,000
New +$572K 0.21% 52

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Ghost Tree Capital's ROIV Position: Q3 2024 in Review

Ghost Tree Capital reduced its Roivant Sciences (ROIV) stake by 20% in Q3 2024, selling an estimated $2.28M and leaving 800,000 shares worth $9.23M. The position accounts for 2.79% of the portfolio, ranked #10.

Ghost Tree Capital first reported a position in ROIV in Q2 2023 and has held it in 6 quarters since. The position peaked at $13.7M in Q1 2024. 293 funds tracked by Wall St. Rank hold ROIV as of Q3 2024.

  • Ghost Tree Capital held 800,000 shares of Roivant Sciences worth $9.23M as of Q3 2024.
  • Ghost Tree Capital sold 200,000 Roivant Sciences shares in Q3 2024, an estimated $2.28M.
  • Roivant Sciences made up 2.79% of Ghost Tree Capital's portfolio in Q3 2024, its #10 holding.
  • Ghost Tree Capital first reported a position in Roivant Sciences in Q2 2023 and has held it in 6 quarters since.
  • Ghost Tree Capital's Roivant Sciences position peaked at $13.7M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.